Christopher P. Leamon

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

Nikki Parker, Mary Jo Turk, Elaine Westrick et al. · Analytical Biochemistry · 2005 · 1.2K citations

Tumor Biology, Normal Tissues, Malignant Disease +10

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Christopher P. Leamon, Philip S. Low · Proceedings of the National Academy of Sciences · 1991 · 557 citations

Lipid Peroxidation, Cell Culture, Cellular Physiology +19

Folate-mediated targeting: from diagnostics to drug and gene delivery

Christopher P. Leamon, Philip S. Low · Drug Discovery Today · 2001 · 368 citations

Drug Targeting, Medicine, Tumor Targeting +3

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 227 citations

Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery

Chrystal M. Paulos, Joseph A. Reddy, Christopher P. Leamon et al. · Molecular Pharmacology · 2004 · 216 citations